Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exenatide BID Compared With Insulin Glargine to Change Liver Fat Content in Non-alcoholic Fatty-liver Disease Patients With Type 2 Diabetes

NCT02303730 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT02303730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02303730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exenatide BID Compared With Insulin Glargine to Change Liver Fat Content in Non-alcoholic Fatty-liver Disease Patients With Type 2 Diabetes
Lead sponsor
Fudan University
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2015
Completion date
November 30, 2017
Enrollment
76 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, non-alcoholic fatty liver disease